OOIR: Observatory of International Research

Papers

(The H4-Index of Europace is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?	497
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	345
Atrial cardiomyopathy delays the endothelialization process of left atrial appendage occluders	303
Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement	258
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	213
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation	209
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	167
Transvenous lead extraction: Experience of the Tandem approach	162
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	158
Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the nat	144
Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	144
The Wolff–Parkinson–White pattern in neonates: results from a large population-based cohort study	133
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review	112
Carbon footprint of atrial fibrillation catheter ablation	111
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained	108
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	104
Impact of pulsed-field ablation on kidney function	101
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	101
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	100
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	95
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	93
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	93
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	84
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	80
Failed shocks in hypertrophic cardiomyopathy patients: prevalence, predictors and outcome	78

Left bundle branch area pacing: predictors of success	77
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	72
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	71
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	65
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	65
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	64
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	62
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	62
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	62
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	62
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	62
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	61
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	59
Prevalence and clinical impact of major incidental findings detected on routine cardiovascular resonance imaging prior to catheter ablation of atrial fibrillation	58
Computed tomography as a predictive tool for ventricular tachycardia	57
Interpolation of electrophysiology parameters using OpenEP: technology development and clinical application	56
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	56
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	55
Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium	55
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	54
Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	54
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	52
Pre-diabetes increases the risk of heart failure among patients with nonvalvular atrial fibrillation	51
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	50
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	50
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	50
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	50